Chemical Compound

Udp-3-hmaglc

CAS Registry Number 108636-29-9
Back to search Request a Quote
Udp-3-hmaglc chemical structure
Primary Record

Udp-3-hmaglc

In stock
4,140 g
Purity
98.9 %
CAS
108636-29-9

Compound Identifiers & Properties

CAS
108636-29-9
PubChem CID
194791
SMILES
CCCCCCCCCCC[C@H](CC(=O)O[C@@H]1[C@H]([C@H](O[C@@H]([C@H]1O)CO)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)NC(=O)C)O
Canonical SMILES
CCCCCCCCCCC[C@@H](O)CC(=O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)[C@@H]1NC(C)=O

Names & Synonyms

  • Udp-3-hmaglc
  • UDP-3-O-acyl-GlcNAc
  • AC1L4YWE
  • AC1Q6SAA
  • RefChem:933852
  • 108636-29-9
  • orb1981763
  • CHEBI:61537
  • UDP-OHMYR-ACETYLGLUCOSAMINE
  • DTXSID701102965
  • KST-1A0800
  • HY-N8515
  • UDP-3-O-(3-hydroxymyristoyl)-N-acetylglucosamine
  • AR-1A2888
  • CID194791
  • UDP-3-O[R-3-Hydroxymyristoyl]-GlcNAc
  • CS-0145497
  • J1.072.857F
  • C04738
  • UDP-3-O-(beta-hydroxymyristoyl)-N-acetylglucosamine
  • UDP-3-O-[(3R)-3-hydroxytetradecanoyl]-N-acetyl-alpha-glucosamine
  • UDP-3-O[R-3-Hydroxymyristoyl]-N-acetylglucosamine
  • Q27131136
  • UDP-3-O-(3-hydroxytetradecanoyl)-N-acetylglucosamine
  • (S)-2-BOC-AMINO-PENT-4-ENOIC ACID BENZYL ESTER
  • [(2R,3R,4R,5S,6R)-3-acetamido-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl] (3R)-3-hydroxytetradecanoate
  • UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine
  • UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine
  • (2r,3r,4r,5s,6r)-3-(acetylamino)-2-{[{[{[(2r,3s,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-4-yl(3r)-3-hydroxytetradecanoate(non-preferred name)
  • UDP-3-O[R-3-Hydroxymyristoyl]-N-acetylglucosamine Discontinued
  • Uridine-5'-Diphosphate-3-O-(R-3-Hydroxymyristoyl)-N-Acetyl-D-Glucosamine
  • UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetyl-alpha-D-glucosamine
  • UDP-3-O-[(3R)-3-hydroxytetradecanoyl]-N-acetyl-|A-glucosamine
  • (3R)-(2R,3R,4R,5S,6R)-3-Acetamido-2-(((((((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl 3-hydroxytetradecanoate
  • 118520-80-2
  • uridine 5'-(3-{2-acetamido-2-deoxy-3-O-[(3R)-hydroxytetradecanoyl]-alpha-D-glucopyranosyl} dihydrogen diphosphate)
  • (2R,3R,4R,5S,6R)-3-(acetylamino)-2-{[(R)-{[(S)-{[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl (3R)-3-hydroxytetradecanoate (non-preferred name)
  • {[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2R,3R,4R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)-4-{[(3R)-3-hydroxytetradecanoyl]oxy}oxan-2-yl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid
  • N-((2R,3R,4R,5S,6R)-2-(((((((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)-5-hydroxy-6-(hydroxymethyl)-4-(((3R)-3-hydroxytetradecanoyl)oxy)oxan-3-yl)ethanimidic acid
  • U20
  • Uridine 5 -[diphosphoric acid beta-[2-(acetylamino)-3-O-[(R)-3-hydroxytetradecanoyl]-2-deoxy-alpha-D-glucopyranosyl]] ester
  • Uridine 5 -[diphosphoric acid P2-[3-O-[(R)-3-hydroxymyristoyl]-2-(acetylamino)-2-deoxy-alpha-D-glucopyranosyl]] ester
  • Uridine 5 -diphosphoric acid beta-[2-(acetylamino)-3-O-[(R)-3-hydroxymyristoyl]-2-deoxy-alpha-D-glucopyranosyl] ester
  • Uridine 5'-(trihydrogen diphosphate), P'-(2-(acetylamino)-2-deoxy-3-O-((3R)-3-hydroxy-1-oxotetradecyl)-alpha-D-glucopyranosyl) ester